Capricor announced it intends to file a BLA for deramiocel for treatment of patients with DMD cardiomyopathy. Click here to ...

Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Capricor Therapeutics (CAPR – Research Report). The ...

Rep. Frank Pallone (D-Long Branch)’s Cardiomyopathy Health, Education, Awareness, Research, and Training in Schools (HEARTS) ...

Capricor Therapeutics Inc (NASDAQ:CAPR) shares are trading higher Tuesday after the company announced intent to file a ...

Better imaging parameters may exist for risk stratification in nonischemic dilated cardiomyopathy (NIDCM), based on a ...

Discover BridgeBio Pharma's groundbreaking patent for treating ATTR cardiomyopathy with Compound 1, showcasing improved patient outcomes and reduced mortality rates.

Background Participation in regular exercise activities is recommended for patients with chronic heart failure. However, less ...

Diagnosis requires left ventricular regional wall motion abnormalities that extend beyond a single coronary artery distribution in the absence of obstructive coronary artery disease. Approximately ...

Edgewise stock soars on positive data from an early-stage study and Part A of a mid-stage study of EDG-7500 in obstructive hypertrophic cardiomyopathy patients.

Edgewise Therapeutics stock skyrocketed on Thursday after a single dose of its drug improved heart function in cardiomyopathy patients.

Keith Gandal, professor of English in the Division of Humanities and the Arts at The City College of New York, and his ...

For people having surgery unrelated to their hearts, new guidelines detail how to manage heart and stroke risks before, ...